Literature DB >> 17587815

Matrix metalloproteinase-induced malignancy in mammary epithelial cells.

Melody Stallings-Mann1, Derek Radisky.   

Abstract

In development, epithelial-mesenchymal transition (EMT) allows interconnected sheets of epithelial cells to reorganize and to pass into and through the surrounding extracellular matrix (ECM). In cancer, EMT-associated processes facilitate invasive growth and development of metastases. Matrix metalloproteinases (MMPs) are enzymes capable of degrading the ECM and altering cell-cell and cell-ECM interactions. MMPs are upregulated in nearly all tumor types, have been shown to induce EMT in cultured cells, and are involved in the development of tumor formation, invasion, and metastasis. We have identified the induction of Rac1b, an alternatively spliced variant of Rac1, as a key event in MMP-induced EMT. Induction of the Rac1b isoform leads to increased cellular reactive oxygen species (ROS), which causes in turn upregulation of Snail, a transcription factor previously implicated in physiological and pathological EMT. MMP/Rac1b-induced ROS also causes DNA damage and induces genomic instability. These findings reveal a new pathway in which a key element of the tumor microenvironment directly stimulates the phenotypic and genotypic alterations involved in malignant transformation, and provides many opportunities for investigation of therapeutic interventions. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17587815     DOI: 10.1159/000101310

Source DB:  PubMed          Journal:  Cells Tissues Organs        ISSN: 1422-6405            Impact factor:   2.481


  24 in total

1.  What does matrix metalloproteinase-1 expression in patients with breast cancer really tell us?

Authors:  Ferdinando Mannello
Journal:  BMC Med       Date:  2011-08-11       Impact factor: 8.775

2.  Possible role of NFkappaB in the embryonic vascular remodeling and the endothelial mesenchymal transition process.

Authors:  Enrique Arciniegas; Luz M Carrillo; Juan B De Sanctis; Daniel Candelle
Journal:  Cell Adh Migr       Date:  2008-01-23       Impact factor: 3.405

Review 3.  Laminin-332-integrin interaction: a target for cancer therapy?

Authors:  Daisuke Tsuruta; Hiromi Kobayashi; Hisayoshi Imanishi; Koji Sugawara; Masamitsu Ishii; Jonathan C R Jones
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

4.  Clinical significance of serum COL6A3 in pancreatic ductal adenocarcinoma.

Authors:  Christopher Y Kang; Jonathan Wang; Dierdre Axell-House; Pranay Soni; Mon-Li Chu; Galina Chipitsyna; Konrad Sarosiek; Jocelyn Sendecki; Terry Hyslop; Mazhar Al-Zoubi; Charles J Yeo; Hwyda A Arafat
Journal:  J Gastrointest Surg       Date:  2013-09-04       Impact factor: 3.452

5.  The metabolism of proline as microenvironmental stress substrate.

Authors:  James M Phang; Jui Pandhare; Yongmin Liu
Journal:  J Nutr       Date:  2008-10       Impact factor: 4.798

6.  Analysis of constant tissue remodeling in Syrian hamster Harderian gland: intra-tubular and inter-tubular syncytial masses.

Authors:  Ana Coto-Montes; Marina García-Macía; Beatriz Caballero; Verónica Sierra; María J Rodríguez-Colunga; Russel J Reiter; Ignacio Vega-Naredo
Journal:  J Anat       Date:  2013-03-17       Impact factor: 2.610

7.  Characterization of EHop-016, novel small molecule inhibitor of Rac GTPase.

Authors:  Brenda L Montalvo-Ortiz; Linette Castillo-Pichardo; Eliud Hernández; Tessa Humphries-Bickley; Alina De la Mota-Peynado; Luis A Cubano; Cornelis P Vlaar; Suranganie Dharmawardhane
Journal:  J Biol Chem       Date:  2012-03-01       Impact factor: 5.157

8.  Involvement of hnRNP A1 in the matrix metalloprotease-3-dependent regulation of Rac1 pre-mRNA splicing.

Authors:  Federico Pelisch; Davitte Khauv; Guillermo Risso; Melody Stallings-Mann; Matías Blaustein; Leandro Quadrana; Derek C Radisky; Anabella Srebrow
Journal:  J Cell Biochem       Date:  2012-07       Impact factor: 4.429

9.  Type IV collagen is a tumour stroma-derived biomarker for pancreas cancer.

Authors:  D Ohlund; C Lundin; B Ardnor; M Oman; P Naredi; M Sund
Journal:  Br J Cancer       Date:  2009-06-02       Impact factor: 7.640

Review 10.  Micro- and nanoscale engineering of cell signaling.

Authors:  L C Kam; K Shen; M L Dustin
Journal:  Annu Rev Biomed Eng       Date:  2013       Impact factor: 9.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.